PRQR Latest Press Releases, Proqr Therapeuti Corporate News

Open account

Releases

2.000

+0.50%

0.010

All
Financials
Insiders

6-K | ProQR Therapeutics N.V.(0001612940)
Apr 19,2024 07:07
20-F | ProQR Therapeutics N.V.(0001612940)
Mar 13,2024 08:46
6-K | ProQR Therapeutics N.V.(0001612940)
Mar 13,2024 07:11
6-K | ProQR Therapeutics N.V.(0001612940)
Feb 15,2024 07:48
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 14,2024 06:09
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 09,2024 06:38
6-K | ProQR Therapeutics N.V.(0001612940)
Jan 19,2024 07:09
6-K | ProQR Therapeutics N.V.(0001612940)
Jan 05,2024 07:09
6-K | ProQR Therapeutics N.V.(0001612940)
Dec 08,2023 07:38
6-K | ProQR Therapeutics N.V.(0001612940)
Nov 07,2023 10:02
6-K | ProQR Therapeutics N.V.(0001612940)
Sep 27,2023 07:07
SC 13G | ProQR Therapeutics N.V.(0001612940)
Sep 14,2023 17:21
6-K | ProQR Therapeutics N.V.(0001612940)
Aug 03,2023 07:17
6-K | ProQR Therapeutics N.V.(0001612940)
Aug 01,2023 07:16
CORRESP | ProQR Therapeutics N.V.(0001612940)
May 22,2023 12:36
UPLOAD | ProQR Therapeutics N.V.(0001612940)
May 22,2023 12:36
6-K | ProQR Therapeutics N.V.(0001612940)
May 17,2023 16:06
6-K | ProQR Therapeutics N.V.(0001612940)
May 16,2023 07:17
EFFECT | ProQR Therapeutics N.V.(0001612940)
Apr 25,2023 06:07
424B5 | ProQR Therapeutics N.V.(0001612940)
Apr 24,2023 16:37
6-K | ProQR Therapeutics N.V.(0001612940)
Apr 18,2023 08:06
F-3 | ProQR Therapeutics N.V.(0001612940)
Mar 29,2023 16:56
RW | ProQR Therapeutics N.V.(0001612940)
Mar 29,2023 16:56
20-F | ProQR Therapeutics N.V.(0001612940)
Mar 29,2023 16:09
6-K | ProQR Therapeutics N.V.(0001612940)
Mar 29,2023 08:09
6-K | ProQR Therapeutics N.V.(0001612940)
Mar 10,2023 16:11
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 14,2023 10:14
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 09,2023 17:01
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 09,2023 12:33
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 09,2023 11:59
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Feb 08,2023 06:03
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
Dec 23,2022 16:40
6-K | ProQR Therapeutics N.V.(0001612940)
Dec 23,2022 07:12
6-K | ProQR Therapeutics N.V.(0001612940)
Nov 09,2022 07:07
6-K | ProQR Therapeutics N.V. (0001612940)
Sep 21,2022 16:16
6-K | ProQR Therapeutics N.V.(0001612940)
Aug 11,2022 07:37
6-K | ProQR Therapeutics N.V.(0001612940)
Aug 04,2022 07:24
6-K | ProQR Therapeutics N.V.(0001612940)
Jun 30,2022 16:36
6-K | ProQR Therapeutics N.V.(0001612940)
Jun 01,2022 07:10
SC 13G/A | ProQR Therapeutics N.V. (0001612940)
May 09,2022 15:31
6-K | ProQR Therapeutics N.V. (0001612940)
May 05,2022 16:31
20-F | ProQR Therapeutics N.V. (0001612940)
Apr 29,2022 09:15
6-K | ProQR Therapeutics N.V. (0001612940)
Apr 13,2022 08:02
6-K | ProQR Therapeutics N.V. (0001612940)
Apr 13,2022 07:09
424B5 | ProQR Therapeutics N.V. (0001612940)
Mar 10,2022 08:55
EFFECT | ProQR Therapeutics N.V. (0001612940)
Mar 10,2022 00:15
CORRESP | ProQR Therapeutics N.V. (0001612940)
Mar 07,2022 16:13
F-3 | ProQR Therapeutics N.V. (0001612940)
Mar 01,2022 17:08
6-K | ProQR Therapeutics N.V. (0001612940)
Feb 24,2022 07:39
SC 13G/A | ProQR Therapeutics N.V. (0001612940)
Feb 14,2022 08:10

Webull provides the latest Proqr Therapeuti (PRQR) stock and general news. This information may help you make smarter investment decisions.

About PRQR

ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).